In the liver, glucokinase (GK) regulatory protein (GKRP) negatively modulates the metabolic enzyme GK by locking it in an inactive state in the nucleus. Here, the authors established a high content screening assay in the 384-well microplate format to measure the nucleus-to-cytoplasm translocation of GK by reagents that destabilize the interaction between GK and GKRP. As a cellular model system, primary rat hepatocytes endogenously expressing both GK and GKRP at physiological levels were used. The GK translocation assay was robust, displayed limited day-to-day variability, and delivered good Z′ statistics. The increase of the glucose concentration in the extracellular medium from a low glucose situation (2.8 mM) to beyond its physiological set point value of 5 mM was found to drive GK from the nucleus into the cytoplasm. Likewise, both fructose (converted intracellularly into fructose-1-phosphate) and a known allosteric GK activator were found to induce the export of GK from the nucleus and to synergistically enhance the effects of medium or high glucose concentrations with respect to GK translocation. Transfer of the high content screening format to a semiautomated medium throughput screening platform enabled the profiling of large compound numbers with respect to allosteric activation of GK. (Journal of Biomolecular Screening 2008:837-846) 
INTRODUCTION
M ORE THAN 170 MILLION INDIVIDUALS WORLDWIDE suffer from diabetes mellitus (DM). The eponymous hallmark of DM (diabetes = flow; mellitus = sweet) is the sweet urine of the patients. The sweetness of the urine reflects a general state of hyperglycemia, which may be based on various metabolic defects. Type 1 diabetes mellitus (T1DM) originates from a loss of the insulin-producing beta cells, which reside in the pancreatic islets of Langerhans. T1DM is thought to result from a T-cell-mediated autoimmune attack. 1 However, the vast majority of the DM patients (approximately 90%) are diagnosed with type 2 diabetes mellitus (T2DM). In contrast to T1DM, T2DM has a multifactorial pathogenesis caused by alterations in several gene products. Over the course of several years, after a phase of insulin resistance with a compensatory increased secretion of insulin by the pancreas, the pancreatic islets deteriorate and hyperglycemia develops. In the late stage of the disease, T2DM patients will finally be on insulin-replacement therapy.
Under healthy conditions, the metabolic enzyme glucokinase (GK) possesses a pivotal role in the maintenance of euglycemia. 2 Sensing the glucose level and controlling the metabolic flux in certain cell types, GK helps to drive the plasma glucose level toward the set point of approximately 5 mM. The glucose-sensing properties of GK are brought about by the particular thermodynamic, kinetic, and molecular features of the enzyme. In a virtually irreversible reaction, GK converts glucose to glucose-6-phosphate using MgATP 2as a cofactor. GK displays cooperative kinetics with respect to glucose (Hill coefficient of 1.7 and inflection point at ~4 mM glucose). Analysis of mutations in cases of familial hypoglycemia 3, 4 and structural studies of GK 5 identified an allosteric activator site on GK, which may be targeted by a novel class of antidiabetic drugs. 6 GK is negatively modulated by the GK regulatory protein (GKRP) in the liver. 7 GKRP locks GK as an inactive complex in the nucleus, 8 an effect that can be counteracted by, for example, fructose-1-phosphate. 9 Likewise, elevated levels of glucose, several glucose analogues, and some pharmacological reagents cause a dissociation of GK from GKRP and a subsequent translocation of GK into the cytoplasm. [10] [11] [12] Fluorescence microscopy has been widely employed in academic cell biology research as a nondestructive and sensitive technique to visualize subcellular structures and to monitor intracellular protein translocations. In recent years, the interest of the pharmaceutical industry to study test compounds in cellular, more disease-relevant assays has increased. In particular, a novel technique generally referred to as high content screening (HCS) has been introduced that combines high resolution fluorescence microscopy with automated image analysis. [13] [14] [15] [16] [17] [18] In HCS, an adherent cell layer at the bottom of a microplate (MP) well is labeled with several fluorophores and the biomolecules of interest are observed by fluorescence microscopy, preferentially in parallel at different wavelengths (multiplexing). Appropriate image analysis algorithms are employed to quantify the distribution and brightness of the fluorophorelabeled biomolecules in the cells. In time-course experiments, the kinetics of a pharmaceutical drug effect and respective intracellular protein trafficking events can be monitored.
HCS provides several benefits in comparison with standard high throughput screening (HTS). Conventional cellular HTS examines the mean response of the whole cell population in a well. In contrast, HCS resolves discrete responses of individual cells in an MP well. The individual cells may differ with respect to differentiation, stage of the cell cycle, state of transfection, or due to natural variability. In consequence, heterogeneous pharmaceutical drug effects on mixed cell populations may be dissected in a single MP well. Therefore, HCS enables the implementation of entirely novel assay formats, which do not rely on an overall change of fluorescence or luminescence intensity from the whole MP well.
Moreover, HCS provides the chance to correlate "on-target" drug effects (meaning pharmaceutical effects of a test compound that are directly related to the "targeted" biomolecule of interest) with other phenomena such as cellular toxicity. 19 Compound artifacts including cell lysis or compound autofluorescence are readily discovered.
In this work, we developed an HCS assay to study the effect of GK allosteric activators on the distribution of GK between nucleus and cytoplasm of primary rat hepatocytes.
MATERIALS AND METHODS

Materials
For the GK translocation assay, DMEM without glucose (catalog number 11966-025) for culturing the primary hepatocytes was from Invitrogen (Carlsbad, CA). Glucose (catalog number G7513), Hoechst 33342 ™ (10 mg/ml; catalog number H3570), fetal calf serum (FCS; catalog number 10500-064), penicillin/streptomycin (catalog number 15070-063), and phosphate-buffered saline (PBS; catalog number 14190-094) were from Invitrogen. RO-28-1675 6 was synthesized within Boehringer Ingelheim Pharma GmbH & Co KG (Biberach, Germany).
Bovine serum albumin (BSA; catalog number A3059), saponin (catalog number S4521), and formaldehyde (37%; catalog number 25.2549) were from Sigma-Aldrich (St. Louis, MO). The antiglucokinase antibody (GCK H88; catalog number sc-7908) was from Santa Cruz Biotechnologies (Santa Cruz, CA). An Alexa Fluor 647 ™ (AF647)-labeled goat anti-rabbit antibody (catalog number A21245) was from Invitrogen. 
GK translocation assay
Primary hepatocytes were isolated by collagenase perfusion 20 from the livers of male Wistar[Crl:Wi(Han)] rats weighing 200-300 g (Charles River, Sulzfeld, Germany). The rat primary hepatocytes were plated into BD 384-well assay plates (AP) using a Multidrop ™ 384 dispenser (Thermo Electron Corp., Waltham, MA) with a cell density of 3500 cells per well in 50 μl per well of DMEM supplemented with 10% FCS, 1% penicillin/ streptomycin, 2 mM L-glutamine, 0.1 μg/ml insulin, 100 nM dexamethasone, and 10 nM gentamicin. The AP were incubated in a humidified Cytomat 2 C15 incubator (Heraeus, Hanau, Germany) at 37°C/5% CO 2 . After about 4 h, the AP were removed from the incubator and were washed 3 times using a Bio-Tek ELx405 HT ™ microplate washer (Bio-Tek Instruments; Winooski, VT) with 80 μl of assay buffer (PBS, pH 7.4) per well and cycle, leaving 10 μl per well after each wash cycle. A total of 30 μl per well of DMEM was added to the AP using a Multidrop ™ 384 dispenser. The AP were incubated in a humidified Cytomat 2 C15 incubator at 37°C/5% CO 2 for 12 h.
Fructose or test compounds at 5× of the indicated final concentrations were diluted in DMEM supplemented with glucose at 5× of the indicated final concentrations into a compound buffer dilution plate (CBDP) using the Cybi-Well ™ 384 simultaneous pipettor (CyBio AG, Jena, Germany) allowing for a final DMSO concentration of 1%. Totals of 10 μl per well of these solutions were transferred from the CBDP to the AP using again the Cybi-Well ™ 384 simultaneous pipettor to the indicated final concentrations. The AP were incubated for the indicated time periods (if not otherwise described for 60 min) in a humidified incubator at 37°C/5% CO 2 .
The cells in the AP were fixed and nuclei were stained by adding 50 μl per well of fixation/nuclear staining solution (8% formaldehyde, 2 μM Hoechst 33342 ™ in PBS) using a Multidrop ™ 384 dispenser. After an incubation at room temperature for 30 min, the AP was washed 3 times with 80 μl of PBS per well and cycle, leaving 20 μl per well after each wash cycle.
After the last washing step, the plates were subjected to immunofluorescence staining. The cells were permeabilized and unspecific binding sites were blocked by adding 20 μl per well of permeabilization/blocking solution (2% BSA, 0.1% saponin in PBS) to the AP using a Multidrop ™ 384 dispenser, followed by an incubation for 30 min at room temperature. The AP was again washed 3 times with 80 μl of wash buffer per well and cycle, leaving 20 μl per well after the each wash cycle. A total of 20 μl of primary antibody solution (anti-glucokinase antibody diluted 1:250 in PBS) was added to the cells using a Multidrop ™ 384 dispenser, and the AP was subsequently incubated for 60 min in a humidified incubator at 37 °C/5% CO 2 . The AP was washed 3 times with 80 μl of wash buffer per well and cycle, leaving 20 μl per well after each wash cycle. A total of 20 μl of secondary antibody solution (AF647-conjugated goat anti-rabbit antibody diluted 1:500 in PBS) was added to the cells using a Multidrop ™ 384 dispenser, and the AP was subsequently incubated for 30 min in a humidified incubator at 37 °C/5% CO 2 . The AP was washed 3 times with 80 μl of PBS per well and cycle, leaving 60 μl per well after the last wash cycle. The AP was sealed with an aluminized foil, or in the automated protocols directly proceeded to imaging. Imaging with the IN Cell 3000 Analyzer ™ was performed using the 364-nm laser line for fluorescence excitation of the Hoechst 33342 ™ dye and the 647-nm laser for the AF647/GK signal.
Image analysis
For the GK translocation assay based on fluorometric imaging by the IN Cell Analyzer 3000 ™ , images were analyzed using the TRF2 ™ algorithm (image analysis software supplied together with the IN Cell Analyzer 3000 ™ ). The function of the TRF2 ™ algorithm is described briefly in the Results section. The "Nuc/Cyt ratio" was defined as the ratio of the nuclear and cytoplasmic mean pixel intensities in the red channel. The absolute Nuc/Cyt ratios varied to a certain extent with the rat hepatocyte preparations, the intensity of the immune staining, and the percentage of viable cells. To compare between different experiments, we employed the "Nuc/Cyt index," which is derived from the Nuc/Cyt ratio values by normalizing to the Nuc/Cyt ratio at 2.8 mM glucose in the extracellular medium. The Nuc/Cyt indices displayed a good reproducibility between experiments.
EC 50 determination and statistical data analysis
Using the Microcal ™ Origin ™ version 5.0, dose-response curves were fitted to the equation:
where x is the concentration of the test compound and Hill indicates the Hill coefficient.
Z′ values were calculated as described previously 21 :
Mean high -Mean low SD high is the standard deviation of the "high values" (vehicle-stimulated controls), Mean high is the mean value of the "high values," and SD low and Mean low are the respective numbers for the "low values" (GK activator-stimulated controls).
RESULTS
Monitoring the nucleus-to-cytosol translocation of GK by HCS
Under conditions of low glucose concentrations, GKRP locks GK in an inactive state in the nucleus. Glucose itself, fructose-1-phosphate, or certain known allosteric activators of GK destabilize the interaction between GKRP and GK, thereby activating GK and releasing it from the nucleus to the cytoplasm (scheme in Fig. 1) .
In our work, we employed rat primary hepatocytes seeded into 384-well HCS imaging plates. Hereby, the number of 3500 cells per well ensured that the majority of the cells could establish intercellular contacts. These cell-cell contacts were important for the hepatocytes to assume their normal cytoplasmic morphology. Cells without intercellular contacts frequently displayed a rounded morphology with a cytoplasm reduced to a narrow ring around the nucleus.
The detailed assay protocol is provided in the Materials and Methods section of the article. In brief, the cells were glucose starved for 12 h. Subsequently, they were incubated for 60 min in a humidified incubator at 37 °C/5% CO 2 at variable concentrations of glucose, fructose or test compounds, then treated with a fixation/nuclear staining solution. After washing, the samples were permeabilized and immune stained using an anti-GK antibody. Imaging with the IN Cell 3000 Analyzer ™ was performed using the 364-nm laser line for fluorescence excitation of the Hoechst 33342 ™ dye and the 647-nm laser for the AF647/GK signal.
Image analysis was carried out with an adapted protocol of the TRF2 ™ nuclear trafficking algorithm (illustrated in Fig. 2 GK between the nucleus and the cytoplasm (indicated as "Nuc/Cyt Index"). Figure 2A displays an image section of the red AF647/GK signal where a portion of the nuclei is largely free of GK (indicated by the open arrowheads) and the other portion contains high levels of GK (indicated by the filled arrowheads). The image analysis algorithm identified the nuclei based on the blue Hoechst 33342 ™ staining (overlayed in Fig. 2B with the red AF647/GK signal). Nuclei were detected as pixel accumulations above a specified intensity threshold in the blue channel image. The derived nuclear sampling mask (shown in Fig. 2C ) was eroded by several pixels to achieve a clear separation from the cytoplasmic signal.
To generate a cytoplasmic sampling mask, the image analysis algorithm first expanded the nuclear sampling mask toward the cellular periphery. Subsequently, the algorithm subtracted the area of the nuclear mask that had been expanded by a "safety collar" of the nucleus-proximal peripheral pixels to obtain a clear separation from the nuclear GK signal. Red fluorescence intensity (corresponding to the GK) was then quantified in the nuclear mask area and in the "cytoplasmic" ring region around these nuclei (shown in Fig. 2D) . The nuclear/cytosol expression index ("Nuc/Cyt Index") was calculated as described in the Materials and Methods section based upon the ratio of the nuclear and cytoplasmic fluorescence intensities in the red channel.
Increase of the glucose and fructose concentrations in the extracellular medium-induced nucleus-to-cytosol translocation of GK
Extracellularly added fructose is intracellularly converted to fructose-1-phosphate. Fructose-1-phosphate is known to bind to GKRP and lock GKRP in a conformation that releases GK into the cytoplasm. 9 After 12 h under conditions of glucose starvation, rat primary hepatocytes were exposed to the indicated concentrations of glucose and fructose for 60 min (Fig.  3A) , then formaldehyde fixed and HCS analyzed as described above. The 2.8 mM glucose level is below the physiological plasma glucose set point of 5 mM. Accordingly, several cells displayed a high level of GK localized in the nuclei at this glucose concentration (Fig. 3B) , the corresponding Nuc/Cyt index was calculated as 2.2 ( Table 1 ). An increase of the extracellular glucose concentration to 8.4 mM (i.e., beyond the set point of the physiological plasma glucose level) induced the nucleusto-cytosol translocation of GK in a large portion of the cells (Fig. 3C) , resulting in a Nuc/Cyt index of 1.9 ( Table 1 ). An additional increase of the glucose concentration to 16.8 mM further enhanced the release of GK into the cytoplasm. Overall, the increase of the glucose concentration from 2.8 to 16.8 mM resulted in a decrease of the Nuc/Cyt index from 2.2 to 1.3 ( Table 1) , reflecting the destabilization of the GKRP-GK interaction with higher glucose levels.
The effect of adding extracellular fructose on the distribution of GK is exemplified in Figure 3D for the glucose level of 8.4 mM: 1 mM fructose increased the cytoplasmic shift of GK. The EC 50 values for fructose ( Table 1 ) became smaller with increasing extracellular glucose levels, from an EC 50 value of 0.38 mM at 2.8 mM glucose, via an EC 50 of 0.078 mM at 8.4 mM glucose, to an EC 50 value of 0.027 mM at 16.8 mM glucose. The decrease of the EC 50 value for fructose with an increasing glucose level reflected the destabilization of the GKRP-GK interaction at higher glucose concentrations.
The maximal fructose-driven nucleus-to-cytoplasm translocation of GK was defined by the extracellular glucose concentration. At the lowest measured glucose concentration (2.8 mM), the addition of fructose resulted in a GK translocation from the fructose-free condition with a Nuc/Cyt index of 2.2 to an extrapolated Nuc/Cyt index of 1.2 at high fructose concentrations ( Table 1 ). When the extracellular glucose level surpassed the physiological plasma glucose set point of 5 mM with 8.4 mM of glucose or 16.8 mM of glucose, virtually all GK could be translocated into the cytoplasm reflected by an extrapolated Nuc/Cyt index of 0.8 for high fructose concentrations ( Table 1) .
Influence of the allosteric GK activator RO-28-1675 on the intracellular GK localization with respect to different extracellular glucose levels
Different from the indirect effect of fructose-1-phosphate (acting via modulation of the GKRP binding affinity to GK), RO-28-1675 is known to exert a direct allosterically activating effect on GK. 6 After a 12-h glucose starvation, rat primary hepatocytes were exposed to the indicated concentrations of glucose and RO-28-1675 ( Fig. 4A) , then formaldehyde fixed and HCS analyzed as described above.
Similar to the above fructose titrations, the EC 50 values for RO-28-1675 (Table 1 ) declined with increasing extracellular glucose levels, from an EC 50 of 2.2 μM at 2.8 mM glucose, via an EC 50 of 0.27 μM at 8.4 mM glucose to an EC 50 value of 0.16 μM at 16.8 mM glucose. This decrease of the EC 50 value for RO-28-1675 with an increasing glucose level reflected the destabilization of the GKRP-GK complex at higher glucose concentrations. The increase of potency for RO-28-1675 was particularly prominent, when the extracellular glucose level was increased from 2.8 mM beyond the physiological plasma glucose set point to 8.4 mM, in good agreement with the desired profile of an antidiabetic drug.
Analogously to the above-described fructose experiments, the maximal effect of RO-28-1675 on the nucleus-to-cytoplasm translocation of GK was defined by the extracellular glucose Table 1) . This is the same Nuc/Cyt index as obtained for high fructose concentrations at 2.8 mM glucose. 
Semiautomated compound testing for GK translocation
Rat primary hepatocytes were seeded into 384-well, imaging-suitable MPs to be employed as APs. After a 12-h glucose starvation, these APs were placed in a humified incubator. We then carried out a semiautomated secondary screening The 8.4 mM glucose concentration was chosen, as it represents a blood glucose level above the physiological 5 mM plasma set point, where the GK-GKRP complex is already partially destabilized by the glucose and thereby more amenable to the activity of an antidiabetic drug. The assay signal window at 8.4 mM glucose is still acceptable. In contrast, at significantly higher glucose concentrations such as 16.8 mM the GK-GKRP complex is largely dissociated based solely upon the effects of glucose so that the assay statistics and robustness would drastically deteriorate (see Figs. 3A, 4A) .
To define the assay window, 8 "positive control" wells on each AP were treated with 1 mM fructose in addition to the 8.4 mM glucose, 8 "negative control" wells were treated with only 8.4 mM glucose and vehicle. In the semiautomated runs, the Nuc/Cyt ratios were not normalized to a 2.8 mM glucose condition, so that no normalized Nuc/Cyt indices as above were calculated (see Materials and Methods). The mean Nuc/Cyt ratio values for the positive and negative controls of 7 APs are shown in Figure 5A .
With Z′ values between 0.3 and 0.6 ( Fig. 5A) , we considered the semiautomated assay to be sufficiently robust for dose-response testing.
Exemplary dose-response curves of these semiautomated screening campaigns for 4 test compounds that induce GK translocation are shown in Figure 5B -E. The test compound effect was calculated with respect to the Nuc/Cyt ratio for the 8.4 mM glucose/vehicle controls (set as 0% stimulation) and with respect to the Nuc/Cyt ratio for the 8.4 mM glucose/1 mM fructose controls (defined as 100% stimulation). Whereas compound 4 displayed the same efficacy as fructose, the efficacy of the test compounds 1, 2, and 3 (Figs. 5B-D) exceeded that of fructose.
CONCLUSIONS
GK plays a central role in the maintenance of euglycemia by both integrating excess blood glucose into the intracellular storage form of glycogen and additionally regulating insulin secretion by the pancreas. The modulation of this metabolic pacemaker enzyme offers an attractive point of interference for antidiabetic, pharmacological agents. In the liver, GKRP negatively modulates GK by locking it in an inactive state in the nucleus.
In this work, a fluorescence microscopic assay in the 384well MP format was established to measure the nucleusto-cytoplasm translocation of GK by reagents that destabilize the interaction between GK and GKRP. The employment of primary rat hepatocytes as a cellular model system ensured the physiological, endogenous expression levels of both GK and GKRP. On the experimental downside, the preparation of the primary cells is a cumbersome procedure and gives rise to some variability between different preparations. Further, the dependency of rat hepatocytes on cell-cell contacts and the consequentially rather dense seeding of the cells into the MP well increased the challenge of image analysis. In our opinion, the ultimately obtained Z′ values of between 0.3 and 0.6 are acceptably robust for the drug discovery process but do not reach the Z′ level that we often observe for HCS assays based upon recombinantly overexpressing cells.
The GK redistribution assay reproduced the known effects of glucose, fructose (intracellularly converted to the bioactive form of fructose-1-phosphate), and RO-28-1675 to shift GK from the nucleus to the cytoplasm. Transfer of the HCS format to a semiautomated medium throughput screening platform with all liquid handling steps carried out by automated dispense or pipetting devices enabled the profiling of large test compound numbers with respect to the induction of GK nuclear export.
